Zobrazeno 1 - 10
of 57
pro vyhledávání: '"medicine pricing"'
Autor:
Roger Wiseman, Ilse Truter
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 17, Iss , Pp 100548- (2025)
Access to medicine is fundamental to the provision of equitable health systems. However, availability of affordable quality-assured medicines continues to be poor, especially in Low- and Middle-Income Countries (LMICs). Targeted efforts associated wi
Externí odkaz:
https://doaj.org/article/855ae73768bc4f1883862f06f4aacadc
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objectives: Cancer diagnosis is increasing day by day all over the world. Deaths due to cancer are among the most common causes of death. Access to cancer drugs is a priority of health policies. The aim of this study is to evaluate access to cancer d
Externí odkaz:
https://doaj.org/article/c9e603675d7e49dab29f309714812e0d
Autor:
Francis Kachidza Chiumia, Cynthia Chithope-Mwale, Felix Abikoloni, Vanessa Matchaya, Tadala Gaviyawo, Felix Khuluza
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objective:Lack of access to essential medicines negatively impacts on the quality of healthcare delivery and increases morbidity and mortality, especially to the vulnerable pediatric population. We assessed the availability, pricing, and affordabilit
Externí odkaz:
https://doaj.org/article/8590faa890784b699e7a573a0080c17f
Autor:
Augustina Koduah, Leonard Baatiema, Anna Cronin de Chavez, Anthony Danso-Appiah, Irene A. Kretchy, Irene Akua Agyepong, Natalie King, Timothy Ensor, Tolib Mirzoev
Publikováno v:
Systematic Reviews, Vol 11, Iss 1, Pp 1-27 (2022)
Abstract Background High medicine prices contribute to increasing cost of healthcare worldwide. Many patients with limited resources in sub-Saharan Africa (SSA) are confronted with out-of-pocket charges, constraining their access to medicines. Differ
Externí odkaz:
https://doaj.org/article/6d06b8d12c2e4c1e823dded41d7a2110
Autor:
R. Moodley, F. Suleman
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Affordability and availability of quality medicines to all its citizens has been a key priority area for South Africa since democracy in 1994. In order to introduce transparency in the private market the government introduced the
Externí odkaz:
https://doaj.org/article/897bc2388a35498a8ffe89fd913c4fc0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kah Seng Lee, Long Chiau Ming, Qi Ying Lean, Siew Mei Yee, Rahul Patel, Nur Akmar Taha, Yaman Walid Kassab
Publikováno v:
Journal of Epidemiology and Global Health, Vol 9, Iss 2 (2019)
Externí odkaz:
https://doaj.org/article/b64e3c66a11c43a990c59c8826b2eaf9
Autor:
Varsha Bangalee, Fatima Suleman
Publikováno v:
Health SA Gesondheid: Journal of Interdisciplinary Health Sciences, Vol 21, Iss C, Pp 60-66 (2016)
Background: This research focuses on pharmaceutical competition in South Africa where concurrent pricing legislation is being implemented without monitoring the consequences on generic drug competition and usage. Objective: To examine the relationshi
Externí odkaz:
https://doaj.org/article/0b65069c062947b69447696cab26a694
Publikováno v:
Journal of Market Access & Health Policy, Vol 7, Iss 1 (2019)
Background and objectives: Governments in Asia Pacific (APAC) are increasingly using pharmaceutical pricing strategies to contain rising healthcare costs. The objective of this narrative review is to discuss formal pricing strategies for reimbursed p
Externí odkaz:
https://doaj.org/article/f98da6f7c4f247f49beae75e7c61c123